Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This randomized phase II trial studies how well celecoxib works in treating patients with
cervical intraepithelial neoplasia, a precancerous lesion of the cervix which can develop
into cervical cancer. Celecoxib may be effective in preventing the development of cervical
cancer in patients who have cervical intraepithelial neoplasia.